Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Skinvisible will receive on-going royalties from product sales
Subscribe to our email newsletter
Skinvisible has entered into an exclusive license agreement with Mayquest Pharmaceuticals for the rights for DermSafe, Skinvisible’s patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine flu virus. The license agreement includes Singapore, Malaysia, Thailand, Indonesia and the Philippines.
Under the terms of the agreement, Mayquest will pay an upfront license fee in milestones for the exclusive manufacturing and marketing rights for DermSafe in the territory. Skinvisible will also receive on-going royalties from product sales.
Terry Howlett, president and CEO of Skinvisible, said: “Mayquest is an excellent partner to bring DermSafe to both the retail and healthcare market in Southeast Asia. This agreement represents an important step in accelerating our worldwide approval and commercialization of DermSafe for the prevention of the spread of the swine flu and other viruses and bacteria. Mayquest has strong medical and regulatory contacts along with the financial backing required to bring DermSafe quickly and successfully to market. This is our first licensing agreement for DermSafe and we continue to actively seek and negotiate license agreements for other countries worldwide.”
DermSafe has been proven to kill/inactivate the influenza viruses H1N1 (swine flu), H3N2 and H5N1 (avian bird flu virus) along with other viruses and bacteria. DermSafe, made with Skinvisible’s patented technology Invisicare, remains on the skin for four hours, providing continuous protection. DermSafe contains active ingredient, chlorhexidine gluconate.
Invisicare is Skinvisible’s patented polymer delivery system that offers life-cycle management and enhancements for topically delivered products. It is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time resisting both wash off and perspiration. Invisicare can control the release of actives and reduce irritation. It is non-occlusive and allows for normal skin respiration while protecting against environmental irritants.